Published in Proc Natl Acad Sci U S A on November 19, 2004
An overview of halogen bonding. J Mol Model (2006) 18.56
Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell (2007) 5.95
Halogen bonding: the sigma-hole. Proceedings of "Modeling interactions in biomolecules II", Prague, September 5th-9th, 2005. J Mol Model (2006) 4.28
A medicinal chemist's guide to molecular interactions. J Med Chem (2010) 3.39
Quantitative analysis of molecular surfaces: areas, volumes, electrostatic potentials and average local ionization energies. J Mol Model (2010) 3.35
Specificity of human thymine DNA glycosylase depends on N-glycosidic bond stability. J Am Chem Soc (2006) 2.52
Sigma-hole bonding: molecules containing group VI atoms. J Mol Model (2007) 2.28
Expansion of the sigma-hole concept. J Mol Model (2008) 2.14
6,8-Di-chloro-4-oxochromene-3-carbalde-hyde. Acta Crystallogr Sect E Struct Rep Online (2013) 2.03
Sigma-hole bonding between like atoms; a fallacy of atomic charges. J Mol Model (2008) 2.00
Halogen bonding and the design of new materials: organic bromides, chlorides and perhaps even fluorides as donors. J Mol Model (2007) 1.93
Molecular basis for the recognition of structurally distinct autoinducer mimics by the Pseudomonas aeruginosa LasR quorum-sensing signaling receptor. Chem Biol (2009) 1.88
Adaptive ligand binding by the purine riboswitch in the recognition of guanine and adenine analogs. Structure (2009) 1.84
Σ-holes, π-holes and electrostatically-driven interactions. J Mol Model (2011) 1.63
Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Curr Opin Struct Biol (2010) 1.62
How sequence defines structure: a crystallographic map of DNA structure and conformation. Proc Natl Acad Sci U S A (2005) 1.61
6-Chloro-4-oxo-4H-chromene-3-carb-aldehyde. Acta Crystallogr Sect E Struct Rep Online (2014) 1.60
Halogen bonds as orthogonal molecular interactions to hydrogen bonds. Nat Chem (2009) 1.56
The Halogen Bond. Chem Rev (2016) 1.50
Halogen bond tunability I: the effects of aromatic fluorine substitution on the strengths of halogen-bonding interactions involving chlorine, bromine, and iodine. J Mol Model (2011) 1.43
Blue shifts vs red shifts in sigma-hole bonding. J Mol Model (2008) 1.43
6,8-Di-bromo-4-oxo-4H-chromene-3-carbaldehyde. Acta Crystallogr Sect E Struct Rep Online (2014) 1.42
Testing geometrical discrimination within an enzyme active site: constrained hydrogen bonding in the ketosteroid isomerase oxyanion hole. J Am Chem Soc (2008) 1.41
Directing macromolecular conformation through halogen bonds. Proc Natl Acad Sci U S A (2007) 1.33
Critical role of zinc in hardening of Nereis jaws. J Exp Biol (2006) 1.32
Fluoride ion encapsulation by Mg2+ ions and phosphates in a fluoride riboswitch. Nature (2012) 1.26
The halogen bond in the design of functional supramolecular materials: recent advances. Acc Chem Res (2013) 1.18
Treatment of Halogen Bonding in the OPLS-AA Force Field; Application to Potent Anti-HIV Agents. J Chem Theory Comput (2012) 1.17
Structural basis for cyclic Py-Im polyamide allosteric inhibition of nuclear receptor binding. J Am Chem Soc (2010) 1.15
Using halogen bonds to address the protein backbone: a systematic evaluation. J Comput Aided Mol Des (2012) 1.15
6-Bromo-4-oxo-4H-chromene-3-carb-alde-hyde. Acta Crystallogr Sect E Struct Rep Online (2014) 1.13
Crystal structure of isoflurane bound to integrin LFA-1 supports a unified mechanism of volatile anesthetic action in the immune and central nervous systems. FASEB J (2009) 1.12
Halogen bond tunability II: the varying roles of electrostatic and dispersion contributions to attraction in halogen bonds. J Mol Model (2012) 1.08
The stacked-X DNA Holliday junction and protein recognition. J Mol Recognit (2006) 1.08
Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter. J Med Chem (2010) 1.07
Structure and mechanism of purine-binding riboswitches. Q Rev Biophys (2012) 1.06
Pyridostatin analogues promote telomere dysfunction and long-term growth inhibition in human cancer cells. Org Biomol Chem (2012) 1.05
Crystal structure of iodotyrosine deiodinase, a novel flavoprotein responsible for iodide salvage in thyroid glands. J Biol Chem (2009) 1.05
Halogen bonding (X-bonding): a biological perspective. Protein Sci (2012) 1.05
Molecular surface electrostatic potentials and anesthetic activity. J Mol Model (2006) 1.01
Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates. Mol Pharm (2010) 1.01
Investigation of H-bonding and halogen-bonding effects in dichloroacetic acid: DFT calculations of NQR parameters and QTAIM analysis. J Mol Model (2012) 1.00
A series of α7 nicotinic acetylcholine receptor allosteric modulators with close chemical similarity but diverse pharmacological properties. Mol Pharmacol (2012) 1.00
Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies. J Med Chem (2009) 0.99
A theoretical investigation of the characteristics of hydrogen/halogen bonding interactions in dibromo-nitroaniline. J Mol Model (2012) 0.99
A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora A. ACS Chem Biol (2012) 0.98
Structure-based engineering of internal cavities in coiled-coil peptides. Biochemistry (2005) 0.97
Revealing substitution effects on the strength and nature of halogen-hydride interactions: a theoretical study. J Mol Model (2013) 0.95
In vitro selection and characterization of RNA aptamers binding thyroxine hormone. Biochem J (2007) 0.95
Trends in σ-hole strengths and interactions of F3MX molecules (M = C, Si, Ge and X = F, Cl, Br, I). J Mol Model (2012) 0.95
A mammalian reductive deiodinase has broad power to dehalogenate chlorinated and brominated substrates. J Am Chem Soc (2009) 0.95
Design and synthesis of aryl ether inhibitors of the Bacillus anthracis enoyl-ACP reductase. ChemMedChem (2008) 0.94
Insights into the strength and nature of carbene···halogen bond interactions: a theoretical perspective. J Mol Model (2013) 0.93
The cooperativity between hydrogen and halogen bond in the XY···HNC···XY (X, Y = F, Cl, Br) complexes. J Mol Model (2011) 0.93
Mapping the binding of GluN2B-selective N-methyl-D-aspartate receptor negative allosteric modulators. Mol Pharmacol (2012) 0.92
Halogen Bonding versus Hydrogen Bonding: A Molecular Orbital Perspective. ChemistryOpen (2012) 0.92
Chlorotrinitromethane and its exceptionally short carbon-chlorine bond. Nat Chem (2009) 0.91
Topological analysis of aromatic halogen/hydrogen bonds by electron charge density and electrostatic potentials. J Mol Model (2009) 0.90
Ascochlorin is a novel, specific inhibitor of the mitochondrial cytochrome bc1 complex. Biochim Biophys Acta (2009) 0.89
8-Chloro-4-oxo-4H-chromene-3-carbaldehyde. Acta Crystallogr Sect E Struct Rep Online (2014) 0.89
7-Chloro-4-oxo-4H-chromene-3-carbaldehyde. Acta Crystallogr Sect E Struct Rep Online (2014) 0.88
Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors. PLoS One (2009) 0.87
CREDO: a structural interactomics database for drug discovery. Database (Oxford) (2013) 0.87
Computational model for predicting chemical substituent effects on passive drug permeability across parallel artificial membranes. Mol Pharm (2008) 0.87
Harnessing the potential of halogenated natural product biosynthesis by mangrove-derived actinomycetes. Mar Drugs (2013) 0.87
Discovery of σ-hole interactions involving ylides. J Mol Model (2013) 0.87
PITPs as targets for selectively interfering with phosphoinositide signaling in cells. Nat Chem Biol (2013) 0.86
Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing. J Med Chem (2011) 0.86
Binding site and ligand flexibility revealed by high resolution crystal structures of GluK1 competitive antagonists. Neuropharmacology (2010) 0.85
Theoretical study on cooperative effects between X⋯N and X⋯Carbene halogen bonds (X = F,Cl,Br and I). J Mol Model (2013) 0.84
Combined X-ray, NMR, and kinetic analyses reveal uncommon binding characteristics of the hepatitis C virus NS3-NS4A protease inhibitor BI 201335. J Biol Chem (2011) 0.84
Evaluating the potential for halogen bonding in the oxyanion hole of ketosteroid isomerase using unnatural amino acid mutagenesis. ACS Chem Biol (2009) 0.84
An antitubulin agent BCFMT inhibits proliferation of cancer cells and induces cell death by inhibiting microtubule dynamics. PLoS One (2012) 0.84
Expression of a soluble form of iodotyrosine deiodinase for active site characterization by engineering the native membrane protein from Mus musculus. Protein Sci (2012) 0.84
Crystal structure of 7-bromo-4-oxo-4H-chromene-3-carbaldehyde. Acta Crystallogr Sect E Struct Rep Online (2014) 0.84
Semiempirical Quantum Mechanical Methods for Noncovalent Interactions for Chemical and Biochemical Applications. Chem Rev (2016) 0.84
A multistep single-crystal-to-single-crystal bromodiacetylene dimerization. Nat Chem (2013) 0.83
Modeling organochlorine compounds and the σ-hole effect using a polarizable multipole force field. J Phys Chem B (2014) 0.83
6-Fluoro-4-oxo-4H-chromene-3-carbalde-hyde. Acta Crystallogr Sect E Struct Rep Online (2014) 0.83
A switch between one- and two-electron chemistry of the human flavoprotein iodotyrosine deiodinase is controlled by substrate. J Biol Chem (2014) 0.83
Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections. Arch Biochem Biophys (2013) 0.83
Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives. PLoS One (2013) 0.82
CNXeCl and CNXeBr species as halogen bond donors: a quantum chemical study on the structure, properties, and nature of halogen···nitrogen interactions. J Mol Model (2014) 0.82
6-Chloro-7-fluoro-4-oxo-4H-chromene-3-carbaldehyde. Acta Crystallogr Sect E Struct Rep Online (2014) 0.81
A knowledge-based halogen bonding scoring function for predicting protein-ligand interactions. J Mol Model (2013) 0.81
The transcriptional regulator CprK detects chlorination by combining direct and indirect readout mechanisms. Philos Trans R Soc Lond B Biol Sci (2013) 0.81
Surprising base pairing and structural properties of 2'-trifluoromethylthio-modified ribonucleic acids. J Am Chem Soc (2014) 0.81
Ansamitocin P3 depolymerizes microtubules and induces apoptosis by binding to tubulin at the vinblastine site. PLoS One (2013) 0.81
Gleaning unexpected fruits from hard-won synthetases: probing principles of permissivity in non-canonical amino acid-tRNA synthetases. Chembiochem (2014) 0.81
Halogenated benzimidazole carboxamides target integrin alpha4beta1 on T-cell and B-cell lymphomas. Cancer Res (2010) 0.80
Nature of halogen bonding. A study based on the topological analysis of the Laplacian of the electron charge density and an energy decomposition analysis. J Mol Model (2012) 0.80
Influence of C-5 halogenation of uridines on hairpin versus duplex RNA folding. RNA (2007) 0.80
Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α. PLoS One (2012) 0.80
Interplay between halogen bonds and hydrogen bonds in OH/SH···HOX···HY (X = Cl, Br; Y = F, Cl, Br) complexes. J Mol Model (2012) 0.80
A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus. J Virol (2015) 0.79
Molecular mechanical perspective on halogen bonding. J Mol Model (2012) 0.79
Molecular interaction of a kinase inhibitor midostaurin with anticancer drug targets, S100A8 and EGFR: transcriptional profiling and molecular docking study for kidney cancer therapeutics. PLoS One (2015) 0.79
Rapid experimental SAD phasing and hot-spot identification with halogenated fragments. IUCrJ (2016) 0.78
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Development and testing of a general amber force field. J Comput Chem (2004) 23.29
The Protein Data Bank. Acta Crystallogr D Biol Crystallogr (2002) 14.44
Cation-pi interactions in aromatics of biological and medicinal interest: electrostatic potential surfaces as a useful qualitative guide. Proc Natl Acad Sci U S A (1996) 3.57
Halogen bonding: a paradigm in supramolecular chemistry. Chemistry (2001) 3.13
Experimentally observed conformation-dependent geometry and hidden strain in proteins. Protein Sci (1996) 2.90
Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A. Proteins (2004) 2.51
The extended and eccentric E-DNA structure induced by cytosine methylation or bromination. Nat Struct Biol (2000) 2.28
Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest (2000) 2.05
N-H...O, O-H...O, and C-H...O hydrogen bonds in protein-ligand complexes: strong and weak interactions in molecular recognition. Proteins (2004) 1.75
Alternative binding modes of an inhibitor to two different kinases. Eur J Biochem (2003) 1.41
Biological dehalogenation and halogenation reactions. Chemosphere (2003) 1.40
Halogen-bond geometry: a crystallographic database investigation of dihalogen complexes. Acta Crystallogr B (2003) 1.40
Electrostatic complementarity in an aldose reductase complex from ultra-high-resolution crystallography and first-principles calculations. Proc Natl Acad Sci U S A (2003) 1.38
3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: association with adverse respiratory outcome. Pediatr Res (2003) 1.37
Effect of sequence on the conformation of DNA holliday junctions. Biochemistry (2003) 1.29
Structure of d(GCGAAAGC) (hexagonal form): a base-intercalated duplex as a stable structure. Acta Crystallogr D Biol Crystallogr (2003) 1.20
Structure of rat transthyretin (rTTR) complex with thyroxine at 2.5 A resolution: first non-biased insight into thyroxine binding reveals different hormone orientation in two binding sites. Acta Crystallogr D Biol Crystallogr (2001) 1.18
Eosinophil peroxidase catalyzes bromination of free nucleosides and double-stranded DNA. Biochemistry (2001) 1.13
Crystal structure of d(GCGAAAGCT) containing a parallel-stranded duplex with homo base pairs and an anti-parallel duplex with Watson-Crick base pairs. Nucleic Acids Res (2002) 1.09
Genome evolution in yeasts. Nature (2004) 10.50
Single processing center models for human Dicer and bacterial RNase III. Cell (2004) 8.19
The non-Watson-Crick base pairs and their associated isostericity matrices. Nucleic Acids Res (2002) 5.35
RNAML: a standard syntax for exchanging RNA information. RNA (2002) 5.34
Sequence elements outside the hammerhead ribozyme catalytic core enable intracellular activity. Nat Struct Biol (2003) 4.64
Tools for the automatic identification and classification of RNA base pairs. Nucleic Acids Res (2003) 4.12
The RNA Ontology Consortium: an open invitation to the RNA community. RNA (2006) 3.60
Topology of three-way junctions in folded RNAs. RNA (2006) 3.14
Structure of monomeric yeast and mammalian Sec61 complexes interacting with the translating ribosome. Science (2009) 3.00
Analysis of RNA motifs. Curr Opin Struct Biol (2003) 2.97
The building blocks and motifs of RNA architecture. Curr Opin Struct Biol (2006) 2.94
Recurrent structural RNA motifs, Isostericity Matrices and sequence alignments. Nucleic Acids Res (2005) 2.88
Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding. Nucleic Acids Res (2005) 2.51
Structure of the ribosome-bound cricket paralysis virus IRES RNA. Nat Struct Mol Biol (2006) 2.32
The dynamic landscapes of RNA architecture. Cell (2009) 2.09
Cryo-EM structure and rRNA model of a translating eukaryotic 80S ribosome at 5.5-A resolution. Proc Natl Acad Sci U S A (2010) 1.99
Sequence to Structure (S2S): display, manipulate and interconnect RNA data from sequence to structure. Bioinformatics (2005) 1.97
Crystal structure of a complex between the aminoglycoside tobramycin and an oligonucleotide containing the ribosomal decoding a site. Chem Biol (2002) 1.97
Comparative genomics of protoploid Saccharomycetaceae. Genome Res (2009) 1.96
RNA-Puzzles: a CASP-like evaluation of RNA three-dimensional structure prediction. RNA (2012) 1.88
Frequency and isostericity of RNA base pairs. Nucleic Acids Res (2009) 1.88
A new understanding of the decoding principle on the ribosome. Nature (2012) 1.88
Plasticity of animal genome architecture unmasked by rapid evolution of a pelagic tunicate. Science (2010) 1.86
An mRNA is capped by a 2', 5' lariat catalyzed by a group I-like ribozyme. Science (2005) 1.82
Assemble: an interactive graphical tool to analyze and build RNA architectures at the 2D and 3D levels. Bioinformatics (2010) 1.80
New metrics for comparing and assessing discrepancies between RNA 3D structures and models. RNA (2009) 1.78
TARP auxiliary subunits switch AMPA receptor antagonists into partial agonists. Science (2007) 1.77
Assembly of core helices and rapid tertiary folding of a small bacterial group I ribozyme. Proc Natl Acad Sci U S A (2003) 1.75
Localization of eukaryote-specific ribosomal proteins in a 5.5-Å cryo-EM map of the 80S eukaryotic ribosome. Proc Natl Acad Sci U S A (2010) 1.68
High-resolution cryo-electron microscopy structure of the Trypanosoma brucei ribosome. Nature (2013) 1.66
How sequence defines structure: a crystallographic map of DNA structure and conformation. Proc Natl Acad Sci U S A (2005) 1.61
The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and X-ray crystal structures. Chembiochem (2003) 1.60
Anion binding to nucleic acids. Structure (2004) 1.59
Halogen bonds as orthogonal molecular interactions to hydrogen bonds. Nat Chem (2009) 1.56
Effects of magnesium ions on the stabilization of RNA oligomers of defined structures. RNA (2002) 1.49
Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide. J Mol Biol (2003) 1.47
Molecular modeling of the three-dimensional structure of the bacterial RNase P holoenzyme. J Mol Biol (2003) 1.40
Visualization of macromolecular structures. Nat Methods (2010) 1.34
A pH-responsive riboregulator. Genes Dev (2009) 1.33
Directing macromolecular conformation through halogen bonds. Proc Natl Acad Sci U S A (2007) 1.33
Structure of a folding intermediate reveals the interplay between core and peripheral elements in RNA folding. J Mol Biol (2005) 1.31
Effect of sequence on the conformation of DNA holliday junctions. Biochemistry (2003) 1.29
The ribozyme core of group II introns: a structure in want of partners. Trends Biochem Sci (2009) 1.28
The RNA polymerase III-dependent family of genes in hemiascomycetes: comparative RNomics, decoding strategies, transcription and evolutionary implications. Nucleic Acids Res (2006) 1.28
The RNA structure alignment ontology. RNA (2009) 1.26
Functional hammerhead ribozymes naturally encoded in the genome of Arabidopsis thaliana. Plant Cell (2005) 1.26
RNA as a drug target: the case of aminoglycosides. Chembiochem (2003) 1.25
Molecular recognition of aminoglycoside antibiotics by ribosomal RNA and resistance enzymes: an analysis of x-ray crystal structures. Biopolymers (2003) 1.24
Pronounced instability of tandem IU base pairs in RNA. Nucleic Acids Res (2004) 1.23
A quantitative RNA code for mRNA target selection by the germline fate determinant GLD-1. EMBO J (2010) 1.23
A general protocol for the crystallization of membrane proteins for X-ray structural investigation. Nat Protoc (2009) 1.21
Determination of thermodynamic parameters for HIV DIS type loop-loop kissing complexes. Nucleic Acids Res (2004) 1.21
Caution! DNA crossing: crystal structures of Holliday junctions. J Biol Chem (2003) 1.20
Symmetric K+ and Mg2+ ion-binding sites in the 5S rRNA loop E inferred from molecular dynamics simulations. J Mol Biol (2004) 1.20
Searching genomes for ribozymes and riboswitches. Genome Biol (2007) 1.19
Proximity of conserved U6 and U2 snRNA elements to the 5' splice site region in activated spliceosomes. EMBO J (2006) 1.18
Molecular contacts between antibiotics and the 30S ribosomal particle. Methods Enzymol (2006) 1.18
Definitions and analysis of DNA Holliday junction geometry. Nucleic Acids Res (2004) 1.17
The three-dimensional architecture of the class I ligase ribozyme. RNA (2004) 1.17
Binding of neomycin-class aminoglycoside antibiotics to mutant ribosomes with alterations in the A site of 16S rRNA. Antimicrob Agents Chemother (2006) 1.15
Analysis of the contribution of individual substituents in 4,6-aminoglycoside-ribosome interaction. Antimicrob Agents Chemother (2005) 1.15
The Mg2+ binding sites of the 5S rRNA loop E motif as investigated by molecular dynamics simulations. Chem Biol (2003) 1.15
Sequence-based identification of 3D structural modules in RNA with RMDetect. Nat Methods (2011) 1.15
Mass spectrometric approaches using electrospray ionization charge states and hydrogen-deuterium exchange for determining protein structures and their conformational changes. Mol Cell Proteomics (2003) 1.14
Pichia sorbitophila, an Interspecies Yeast Hybrid, Reveals Early Steps of Genome Resolution After Polyploidization. G3 (Bethesda) (2012) 1.12
RNA structure analysis of human spliceosomes reveals a compact 3D arrangement of snRNAs at the catalytic core. EMBO J (2013) 1.08
The role of halogen bonding in inhibitor recognition and binding by protein kinases. Curr Top Med Chem (2007) 1.07
Classification of pseudo pairs between nucleotide bases and amino acids by analysis of nucleotide-protein complexes. Nucleic Acids Res (2011) 1.06
Distributions of Z-DNA and nuclear factor I in human chromosome 22: a model for coupled transcriptional regulation. Nucleic Acids Res (2004) 1.05
New structural insights into the decoding mechanism: translation infidelity via a G·U pair with Watson-Crick geometry. FEBS Lett (2013) 1.05
Halogen bonding (X-bonding): a biological perspective. Protein Sci (2012) 1.05
Binding of manganese(II) to a tertiary stabilized hammerhead ribozyme as studied by electron paramagnetic resonance spectroscopy. RNA (2005) 1.04
Antibacterial aminoglycosides with a modified mode of binding to the ribosomal-RNA decoding site. Angew Chem Int Ed Engl (2004) 1.04
Monitoring intermediate folding states of the td group I intron in vivo. EMBO J (2002) 1.03
Metal ion binding to RNA. Met Ions Life Sci (2011) 1.03
Two conformational states in the crystal structure of the Homo sapiens cytoplasmic ribosomal decoding A site. Nucleic Acids Res (2006) 1.03
Architecture of a Diels-Alderase ribozyme with a preformed catalytic pocket. Chem Biol (2004) 1.02
Selecting optimum eukaryotic integral membrane proteins for structure determination by rapid expression and solubilization screening. J Mol Biol (2008) 1.02
The RNA structurome: high-throughput probing. Nat Methods (2010) 1.02
Docking of aminoglycosides to hydrated and flexible RNA. J Med Chem (2006) 1.01
Toward predicting self-splicing and protein-facilitated splicing of group I introns. RNA (2008) 1.00
Differential selectivity of natural and synthetic aminoglycosides towards the eukaryotic and prokaryotic decoding A sites. Chembiochem (2007) 0.99
Architecture and folding mechanism of the Azoarcus Group I Pre-tRNA. J Mol Biol (2004) 0.98
RNA structure: bioinformatic analysis. Curr Opin Microbiol (2007) 0.98
Hydrophobic Groups Stabilize the Hydration Shell of 2'-O-Methylated RNA Duplexes. Angew Chem Int Ed Engl (2001) 0.98
MAO: a Multiple Alignment Ontology for nucleic acid and protein sequences. Nucleic Acids Res (2005) 0.97
The bacterial and mitochondrial ribosomal A-site molecular switches possess different conformational substates. Nucleic Acids Res (2008) 0.97
Phylogenomic analysis of the emergence of GC-rich transcription elements. Proc Natl Acad Sci U S A (2007) 0.97
Structure-activity relationships among the kanamycin aminoglycosides: role of ring I hydroxyl and amino groups. Antimicrob Agents Chemother (2012) 0.95
Molecular modelling of the GIR1 branching ribozyme gives new insight into evolution of structurally related ribozymes. EMBO J (2008) 0.95
Brownian-dynamics simulations of metal-ion binding to four-way junctions. Nucleic Acids Res (2002) 0.95
Structure-based design, synthesis and A-site rRNA co-crystal complexes of novel amphiphilic aminoglycoside antibiotics with new binding modes: a synergistic hydrophobic effect against resistant bacteria. Bioorg Med Chem Lett (2010) 0.93
Crystal structure of the bacterial ribosomal decoding site complexed with amikacin containing the gamma-amino-alpha-hydroxybutyryl (haba) group. Biochimie (2006) 0.93
Comparative genomics of emerging pathogens in the Candida glabrata clade. BMC Genomics (2013) 0.92
Crystal structure of the Homo sapiens cytoplasmic ribosomal decoding site complexed with apramycin. Angew Chem Int Ed Engl (2006) 0.92
The effect of cytosine methylation on the structure and geometry of the Holliday junction: the structure of d(CCGGTACm5CGG) at 1.5 A resolution. J Biol Chem (2002) 0.92
Mutation in a primate-conserved retrotransposon reveals a noncoding RNA as a mediator of infantile encephalopathy. Proc Natl Acad Sci U S A (2012) 0.91
Topolins and hydroxylated thidiazuron derivatives are substrates of cytokinin O-glucosyltransferase with position specificity related to receptor recognition. Plant Physiol (2005) 0.91